News

BioPharma Dive10d
AstraZeneca blood pressure drug succeeds in late-stage trial
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...
Mayor confirms Petersburg is courting AstraZeneca to build billion-dollar facility here
AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.
BioSpace10d
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase III Trial
The drug came to AstraZeneca through its acquisition of CinCor Pharma in 2023, with the hopes of beefing up its ...
AstraZeneca (LSE:AZN) Unveils Promising Phase III Results For Baxdrostat In Hypertension Trial
AstraZeneca (LSE:AZN) recently experienced a weekly price move of 2% amid announcements that could have supported its ...
AstraZeneca shares show signs of life after successful trials of hypertension drug
Positive high-level results in trials of its baxdrostat drug to treat hypertension provided AstraZeneca shares with a ...
PMLive9d
AstraZeneca’s baxdrostat shows promise in phase 3 hypertension study
The phase 3 BaxHTN trial has been evaluating two doses of the drug in patients with uncontrolled hypertension being treated ...
Boost for AstraZeneca after successful trial of experimental blood pressure drug
Astra said its experimental drug Baxdrostat reduced the blood pressure of patients who have a treatment-resistant form of ...
AstraZeneca drug lowers high blood pressure in late-stage study; shares rise
AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...
Chromatography Online1d
AstraZeneca Commits $50 Billion to U.S. Manufacturing and R&D Expansion
The company plans to invest billions in a new drug manufacturing hub in Virginia, dedicated to chronic disease treatments, alongside additional facilities in California, Indiana, Maryland, ...